Avaliação das características do líquido ruminal, hemogasometria, atividade pedométrica e diagnóstico de laminite subclínica em vacas leiteiras

Este estudo objetivou avaliar as características do líquido ruminal, hemogasometria, atividade pedométrica e ocorrência laminite subclínica, por meio da presença de enfermidades podais secundárias, em vacas leiteiras de alta produção, provenientes de um rebanho comercial. Foram avaliadas 200 vacas holandesas, oriundas da mesma propriedade, localizada na região de Araçatuba, SP, divididas em quatro grupos, sendo estes estabelecidos a partir da produtividade diária. Inicialmente procedeu-se o exame clínico dos animais, seguido da colheita de amostras do líquido ruminal, por meio de sondagem esofágica, sendo este avaliado quanto ao pH, cor, odor, consistência, sedimentação, flutuação e prova de redução pelo azul de metileno. Também foram colhidas amostras de sangue venoso para hemogasometria, além da coleta dos dados da pedometria (número de passos) e produção de leite diária das vacas. Os dados obtidos foram tabulados e submetidos à análise de correlação. Nenhum animal avaliado apresentou alterações no pH ruminal, bem como não foram encontrados distúrbios do desequilíbrio ácido básico, pois os valores de pH sanguíneo, PCO2, TCO2, HCO3- e EB estavam dentro da normalidade, durante a análise hemogasométrica. A pedometria foi efetiva como método de triagem para as vacas acometidas de afecções podais, pois se observou a redução no número de passos devido à dor, correlacionada a menor produção leiteira. Contudo, a identificação destas afecções, somente foi possível mediante exame clínico específico dos dígitos. A ocorrência das afecções podais em 49,5% do rebanho deveu-se aos fatores de riscos presentes na propriedade, como o concreto abrasivo e instalações inadequadas, associados também a possível ocorrência de acidose ruminal subaguda, não diagnosticada pela metodologia utilizada. A correlação entre os valores do pH ruminal, pedometria e hemogasometria se mostrou eficiente para o diagnóstico precoce das afecções podais e também no estabelecimento da etiologia destas enfermidades. A laminite subclínica acometeu primariamente as vacas do rebanho, considerando a etiologia multifatorial desta afecção, ocorrência e distribuição das enfermidades podais diagnosticadas

Cohort profile : Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - The FOCUS Consortium

Purpose The overarching goal of the FOCUS (biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer (CRC) recurrence and survival) Consortium is to unravel the effect of folate and folate-mediated one-carbon metabolism (FOCM) biomarkers on CRC prognosis to provide clinically relevant advice on folate intake to cancer patients and define future tertiary prevention strategies. Participants The FOCUS Consortium is an international, prospective cohort of 2401 women and men above 18 years of age who were diagnosed with a primary invasive non-metastatic (stages I-III) CRC. The consortium comprises patients from Austria, two sites from the Netherlands, Germany and two sites from the USA. Patients are recruited after CRC diagnosis and followed at 6 and 12 months after enrolment. At each time point, sociodemographic data, data on health behaviour and clinical data are collected, blood samples are drawn. Findings to date An increased risk of cancer recurrences was observed among patients with higher compared with lower circulating folic acid concentrations. Furthermore, specific folate species within the FOCM pathway were associated with both inflammation and angiogenesis pathways among patients with CRC. In addition, higher vitamin B 6 status was associated with better quality of life at 6 months post-treatment. Future plans Better insights into the research on associations between folate and FOCM biomarkers and clinical outcomes in patients with CRC will facilitate the development of guidelines regarding folate intake in order to provide clinically relevant advice to patients with cancer, health professionals involved in patient care, and ultimately further tertiary prevention strategies in the future. The FOCUS Consortium offers an excellent infrastructure for short-term and long-term research projects and for combining additional biomarkers and data resulting from the individual cohorts within the next years, for example, microbiome data, omics and multiomics data or CT-quantified body composition data

Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer : results from the FOCUS consortium

BACKGROUND: B vitamins have been associated with the risk and progression of colorectal cancer (CRC), given their central roles in nucleotide synthesis and methylation, yet their association with quality of life in established CRC is unclear. OBJECTIVES: To investigate whether quality of life 6 months postdiagnosis is associated with: 1) circulating concentrations of B vitamins and related biomarkers 6 months postdiagnosis; 2) changes in these concentrations between diagnosis and 6 months postdiagnosis; 3) B-vitamin supplement use 6 months postdiagnosis; and 4) changes in B-vitamin supplement use between diagnosis and 6 months postdiagnosis. METHODS: We included 1676 newly diagnosed stage I-III CRC patients from 3 prospective European cohorts. Circulating concentrations of 9 biomarkers related to the B vitamins folate, riboflavin, vitamin B6, and cobalamin were measured at diagnosis and 6 months postdiagnosis. Information on dietary supplement use was collected at both time points. Health-related quality of life (global quality of life, functioning scales, and fatigue) was assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 6 months postdiagnosis. Confounder-adjusted linear regression analyses were performed, adjusted for multiple testing. RESULTS: Higher pyridoxal 5'-phosphate (PLP) was cross-sectionally associated with better physical, role, and social functioning, as well as reduced fatigue, 6 months postdiagnosis. Associations were observed for a doubling in the hydroxykynurenine ratio [3-hydroxykynurenine: (kynurenic acid + xanthurenic acid + 3-hydroxyanthranilic acid + anthranilic acid); an inverse marker of vitamin B6] and both reduced global quality of life (β = -3.62; 95% CI: -5.88, -1.36) and worse physical functioning (β = -5.01; 95% CI: -7.09, -2.94). Dose-response relations were observed for PLP and quality of life. No associations were observed for changes in biomarker concentrations between diagnosis and 6 months. Participants who stopped using B-vitamin supplements after diagnosis reported higher fatigue than nonusers. CONCLUSIONS: Higher vitamin B6 status was associated with better quality of life, yet limited associations were observed for the use of B-vitamin supplements. Vitamin B6 needs further study to clarify its role in relation to quality of life

Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry

Background Atrial fibrillation (AF) promotes atrial remodeling that in turn promotes AF perpetuation. The aim of our study is to investigate the impact of AF history length on 1-year outcome of AF catheter ablation in a cohort of patients enrolled in the Atrial Fibrillation Ablation Registry. Methods We described the real-life clinical epidemiology, therapeutic strategies, and the short- and mid-term outcomes of 1948 patients (71.9% with paroxysmal AF) undergoing AF ablation procedures, stratified according to AF history duration (= 2 years). Results The mean AF history duration was 46.2 +/- 57.4 months, 592 patients had an AF history duration = 2 years (mean 75.5 +/- 63.5 months) (P = 2 years (34.0%) (P = 0.037). AF history duration >= 2 years, overall ablation procedure duration, hypertension, and chronic kidney disease were all predictors of recurrences after the blanking period. Conclusions In this multicenter registry, performing catheter ablation in patients with an AF history >= 2 years was associated with higher rates of AF recurrences at 1 year. Since cumulative time in AF in not necessarily equivalent to AF history, its role remains to be clarified.Cardiolog